About Erlotinib Hydrochloride
Class: | Tyrosine kinase inhibitor
Use: | Treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer
Adult dose: | 150 mg orally once daily, taken at least 1 hour before or 2 hours after meals
Pediatric dose: | Safety and efficacy not established in pediatric patients
Side effects: | Rash, diarrhea, nausea, fatigue, loss of appetite, and liver enzyme elevations
Contraindications: | Hypersensitivity to erlotinib or any component of the formulation; pregnancy and breastfeeding
Drug Class
Tyrosine kinase inhibitor
Uses & Indications
Treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer
Storage Requirements
Store at room temperature (20°C to 25°C or 68°F to 77°F); protect from moisture and light
Manufacturer & Packaging
Manufacturer: F. Hoffmann-La Roche Ltd., SWITZERLAND
Package Size
30's (10's Blister x 3)
Price & Supplier
Price in UAE: AED 13727.00
Dosage Information
Adult Dose
150 mg orally once daily, taken at least 1 hour before or 2 hours after meals
Pediatric Dose
Safety and efficacy not established in pediatric patients
Side Effects
Rash, diarrhea, nausea, fatigue, loss of appetite, and liver enzyme elevations
Contraindications & Precautions
Hypersensitivity to erlotinib or any component of the formulation; pregnancy and breastfeeding
Important Warnings
Risk of interstitial lung disease (ILD), hepatotoxicity, gastrointestinal perforation, and serious skin reactions; monitor liver function and for signs of ILD during treatment
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.